FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company Vertex Pharmaceuticals on Thursday. The drug, which is called suzetrigine and will be sold under the brand name Journavx, is the first new type of pain medicine approved by the agency in more than 20 years.
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...
Life Science Washington, the state’s life sciences industry association, today announced the expansion of its board of directors with the addition of nine new members, representing distinguished ...
BMO Capital analyst Evan Seigerman raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $545 from $520 and keeps an Outperform ...
NBC News on MSN13d
'Will it really work?': Young sickle cell patient among the first to start new gene therapySince two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...
Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...
Fox News correspondent Alexandria Hoff has the latest on President Donald Trump’s comments regarding the aircraft collision near Washington, D.C. and more on ‘Special Report.’ ...
Analyst Michael Yee of Jefferies maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback